FDA Person
FDATiara N Brown-Crosen
View detailed information about Tiara N Brown-Crosen, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 32 inspections of 32 companies, 2016–2019.
Inspections (32)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| April 19, 2019 | Sentio Biosciences LLC | VAI | Drug Quality Assurance | #1087848 |
| February 26, 2019 | Avantor Performance Materials India Limited | NAI | Drug Quality Assurance | #1085725 |
| February 22, 2019 | Reliance Life Sciences Private Limited | VAI | Generic Drug Evaluation | #1081821 |
| February 15, 2019 | Harman Finochem Limited | NAI | Drug Quality Assurance | #1083422 |
| January 17, 2019 | Particle Dynamics International LLC | NAI | Drug Quality Assurance | #1077735 |
| November 16, 2018 | Bal Pharma Limited- Unit 2 | VAI | Drug Quality Assurance | #1075221 |
| November 8, 2018 | R.L. Fine Chem Private Limited | Not classified | #1074755 | |
| November 2, 2018 | Lee Pharma Ltd. | VAI | Drug Quality Assurance | #1072736 |
| September 19, 2018 | HomeChoice Partners, Inc. dba Bioscrip Infusion Services | Not classified | Drug Quality Assurance | #1066631 |
| August 29, 2018 | NINGBO FST HOME PRODUCTS CO LTD | NAI | Drug Quality Assurance | #1069538 |
| August 24, 2018 | Wuhan Biocause Pharmaceutical Development Co., Ltd. | VAI | Drug Quality Assurance | #1069379 |
| August 17, 2018 | HEC Pharm Co., Ltd. | NAI | Drug Quality Assurance | #1068764 |
| June 8, 2018 | Egis Pharmaceuticals PLC | NAI | Drug Quality Assurance | #1059394 |
| June 1, 2018 | Biotika a.s. | VAI | Drug Quality Assurance | #1057355 |
| March 23, 2018 | Zhejiang Chempacific Corporation | NAI | Drug Quality Assurance | #1050336 |
| March 16, 2018 | Fujian Kerui Pharmaceutical Co., Ltd. | VAI | Drug Quality Assurance | #1048952 |
| March 9, 2018 | Hubei Haosun Pharmaceutical Co., Ltd. | NAI | Drug Quality Assurance | #1047621 |
| January 26, 2018 | Prevention Health Sciences Inc. | Not classified | Drug Quality Assurance | #1038927 |
| December 15, 2017 | Lonza AG | VAI | Drug Quality Assurance | #1035618 |
| November 16, 2017 | Park Avenue Compounding | OAI | Drug Quality Assurance | #1033886 |
Documents (9)
- 483 · Bal Pharma Limited- Unit 2 · November 16, 2018
- 483 · Wuhan Biocause Pharmaceutical Development Co., Ltd. · August 24, 2018
- 483 · Lee Pharma Ltd. · November 2, 2018
- 483 · Biotika a.s. · June 1, 2018
- 483 · Sentio Biosciences LLC · April 19, 2019
- 483 · Lonza AG · December 15, 2017
- 483 · Fujian Kerui Pharmaceutical Co., Ltd. · March 14, 2018
- 483 · Vi Jon, Inc. · January 11, 2017
- 483 · Alcami Carolinas Corporation · March 28, 2017
Frequently inspected with (7)
Steven P Donald
2 shared
Aditi Thakur
1 shared
Ashutosh V. Rao
1 shared
Frances Namuswe
1 shared
Maria J. Lopez- Barragan
1 shared
Robert J. Ham
Investigator?
1 shared
Shanna R. Haden
investigator
1 shared
Person Information
Name
Tiara N Brown-Crosen
Role
ISSUING OFFICER
ID: 8255649d-25a9-49fa-a28d-0cdda922c0c3
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.